塞拉斯特治疗减弱了阿尔茨海默病模型小鼠的炎症反应
Fanfan Cao1, Pan Zhang2, Zelun Zheng3
1Shanghai Health Commission Key Lab of Artificial Intelligence (AI)-Based Management of Inflammation and Chronic Diseases, Department of Central Laboratory, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.
Neurological research
|August 5, 2025
概括
塞拉斯特是一种天然化合物,通过减少炎症来改善阿尔茨海默病 (AD) 模型中的认知功能. 它通过TLR4/NFκB通路促进有益的微质M2极化.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,有效治疗方法有限.
- 迫切需要针对阿尔茨海默病的新型治疗药物.
- 塞拉斯特是一种植物衍生的三烯,具有抗氧化和抗炎性质.
研究的目的:
- 为了研究在阿尔茨海默氏症的治疗潜力.
- 阐明塞拉斯特对神经炎症的影响背后的机制.
主要方法:
- 实验在体内 (AD模型小鼠) 和体外进行.
- 评估了对微质极化和炎症因子表达的塞拉斯治疗效应.
- 研究了TLR4/NFκB通路在塞拉斯特作用中的作用.
主要成果:
- 塞拉斯托尔治疗促进了M2微质极化,并减少了炎症因素.
- 在AD小鼠的认知功能被塞拉斯特显著改善.
- 塞拉斯的保护作用通过TLR4/NFκB通路进行调解,因为TLR4过度表达逆转了益处.
结论:
- 塞拉斯特在阿尔茨海默氏症模型中减轻神经炎症.
- 该机制涉及通过TLR4/NFκB通路促进微质M2极化.
- 塞拉斯特显示出作为阿尔茨海默病的新型治疗剂的潜力.
相关概念视频
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669


